analyze & realize (a&r), the consulting and clinical research organization located in Berlin, has appointed Dr. Andreas Schemenewitz as Managing Director. This appointment is another step towards further enhancing the already first-rate team of a&r in order to support customers with creative ideas and smart innovation processes for regulatory and scientific questions. Dr. Schemenewitz will therefore be working closely together with second acting Managing Director Matthias Miller.
The former head of a&r’s business development department, Dr. Schemenewitz has more than 14 years of experience in the field of contract research and consultancy in both natural health products and pharmaceuticals. He previously held clinical operation positions in pharmaceutical companies such as Janssen-Cilag and Mundipharma Research as well as management positions at contract research organizations such as Scope International and syneed medidata. This expertise will make Dr. Schemenewitz’s contribution as Managing Director exceptionally valuable for the company.
Dr. Schemenewitz replaces Dr. Volker Spitzer, who will be leaving a&r by September 30th, 2017, to pursue other interests. Dr. Spitzer has been instrumental to the success of a&r, having built sustainable and long-lasting relationships with customers. Continuing this work remains the overarching objective of a&r.
a&r second Managing Director, Matthias Miller, said: „I am delighted to welcome Andreas as new Managing Director of a&r. Andreas accumulated a wealth of knowledge and expertise in this field and will expand our company and business upon the great foundation Volker has built over the years.”
Dr. Andreas Schemenewitz, Managing Director of a&r: “I am grateful to have the trust of the company, and I am very much looking forward to the upcoming challenges and tasks. I have been a part of the company for a long time, and I am dedicated to continuing and expanding the great work done here at a&r.”
Berlin September 20th, 2017